52 Publications (Page 1 of 3)
2018
Abstract 3109: Investigating the role of wild-type TFE3 in renal cell carcinoma cells harboring TFE3 fusions with spliceosome machinery associated genes
Damayanti, Nur P⋅Damayanti, Nur P⋅Ahmed, Khunsha⋅Ahmed, Khunsha⋅Elbanna, May⋅Elbanna, May⋅Kao, Chinghai⋅Kao, Chinghai⋅Pili, Roberto and Pili, Roberto
Cancer Research, vol. 78, (no. 13 Supplement), pp. 3109, 2018-07-01. | Journal Article
2010
Antitumor activity of Ad-IU2, a prostate-specific replication-competent adenovirus encoding the apoptosis inducer, TRAIL
Jimenez, J. A⋅Li, X.⋅Zhang, Y-P⋅Bae, K. H⋅Mohammadi, Y.⋅Pandya, P.⋅Kao, Chinghai and Gardner, Thomas A
Cancer Gene Therapy, vol. 17, (no. 3), pp. 180-191, 2010. | Journal Article
2009
Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter
Ahn, M.⋅Lee, S-J⋅Li, X.⋅Jimenez, J. A⋅Zhang, Y-P⋅Bae, K-H⋅Mohammadi, Y.⋅Kao, Chinghai and Gardner, Thomas A
Cancer Gene Therapy, vol. 16, (no. 1), pp. 73-82, 2009. | Journal Article
2008
Anti-angiogenic gene therapy for metastatic renal cell carcinoma produces tumor growth suppression in an athymic nude mouse model.
Mellon, Matthew J⋅Mellon, Matthew⋅Ahn, Miwon⋅Ahn, Miwon⋅Jiménez, Juan A⋅Jiménez, Juan⋅Kao, Chinghai⋅Kao, Chinghai⋅Gardner, Thomas and Gardner, Thomas A
The Journal of urology, vol. 179, (no. 2), pp. 737-42, 2008/Feb. | Journal Article
 
Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy
Li, Xiong⋅Liu, You-Hong⋅Lee, Sang-Jin⋅Gardner, Thomas A⋅Jeng, Meei Huey and Kao, Chinghai
Clinical Cancer Research, vol. 14, (no. 1), pp. 291-299, 2008. | Journal Article
 
Suppression of Renal Cell Carcinoma Growth and Metastasis with Sustained Antiangiogenic Gene Therapy
Mellon, Mj⋅Bae, K-H⋅Steding, Catherine E⋅Jimenez, JA⋅Jiménez, Juan A⋅Kao, Chinghai and Gardner, Thomas A
Human Gene Therapy, vol. 19, (no. 5), pp. 487-495, 2008. | Journal Article
2007
Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy
Li, Xiong⋅Li, Xiong⋅Liu, You-Hong⋅Liu, You-Hong⋅Zhang, Yan-Ping⋅Zhang, Yan-Ping⋅Zhang, Shaobo⋅Zhang, Shaobo⋅Pu, Xinzhu⋅Pu, Xinzhu⋅Gardner, Thomas A⋅Gardner, Thomas⋅Jeng, Meei Huey⋅Jeng, Meei-Huey⋅Kao, Chinghai and Kao, Chinghai
Clinical Cancer Research, vol. 13, (no. 18), pp. 5463-5473, 2007. | Journal Article
 
Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.
Shirakawa, Toshiro⋅Terao, Shuji⋅Hinata, Nobuyuki⋅Tanaka, Kazushi⋅Takenaka, Atsushi⋅Hara, Isao⋅Sugimura, Kazuro⋅Matsuo, Masafumi⋅Hamada, Katsuyuki⋅Fuji, Kohzo⋅Okegawa, Takatsugu⋅Higashihara, Eiji⋅Gardner, Thomas A⋅Kao, Chinghai⋅Chung, Leland⋅Kamidono, Sadao⋅Fujisawa, Masato and Gotoh, Akinobu
Human gene therapy, vol. 18, (no. 12), pp. 1225-32, 2007/Dec. | Journal Article
2006
Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis
Li, Xiong⋅Jung, Chaeyong⋅Liu, You-Hong⋅Bae, Kyung-hee⋅Zhang, Yan-Ping⋅Zhang, Hong-Ji⋅Vanderputten, Dale⋅Jeng, Meei Huey⋅Gardner, Thomas A and Kao, Chinghai
Journal of Gene Medicine, vol. 8, (no. 6), pp. 679-689, 2006. | Journal Article
 
Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene
Li, Xiong⋅Li, Xiong⋅Raikwar, Sudhanshu⋅Raikwar, Sudhanshu⋅Liu, You-Hong⋅Liu, You-Hong⋅Lee, Sang-Jin⋅Lee, Sang-Jin⋅Zhang, Yan-Ping⋅Zhang, Yan-Ping⋅Zhang, Shaobo⋅Zhang, Shaobo⋅Cheng, Liang⋅Cheng, Liang⋅Lee, Sang-Don⋅Lee, Sang-Don⋅Juliar, Beth E⋅Juliar, Beth⋅Gardner, Thomas⋅Gardner, Thomas A⋅Jeng, Meei Huey⋅Jeng, Meei-Huey⋅Kao, Chinghai and Kao, Chinghai
Molecular Cancer Therapeutics, vol. 5, (no. 3), pp. 676-684, 2006. | Journal Article
 
Current status of anti-angiogenesis therapy for prostate cancer.
Jiménez, Juan A⋅Kao, Chinghai⋅Raikwar, Sudhanshu and Gardner, Thomas A
Urologic oncology, vol. 24, (no. 3), pp. 260-8, 2006 May-Jun. | Journal Article
 
Future innovations in treating advanced prostate cancer.
Desai, Pratik⋅Jiménez, Juan A⋅Kao, Chinghai and Gardner, Thomas A
The Urologic clinics of North America, vol. 33, (no. 2), pp. 247-72, viii, 2006/May. | Journal Article
2005
Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
Raikwar, Sudhanshu⋅Temm, Constance J⋅Raikwar, Nandita S⋅Kao, Chinghai⋅Molitoris, Bruce A and Gardner, Thomas A
Molecular therapy : the journal of the American Society of Gene Therapy, vol. 12, (no. 6), pp. 1091-100, 2005/Dec. | Journal Article
 
Gene Therapy for Prostate Cancer by Controlling Adenovirus E1a and E4 Gene Expression with PSES Enhancer
Li, Xiong⋅Zhang, Yan-Ping⋅Kim, Hong-Sup⋅Bae, Kyung-Hee⋅Stantz, Keith M⋅Lee, Sang-Jin⋅Jung, Chaeyong⋅Jimenez, Juan A⋅Gardner, Thomas A⋅Jeng, Meei Huey and Kao, Chinghai
Cancer Research, vol. 65, (no. 5), pp. 1941-1951, 2005. | Journal Article
 
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
Jung, C.⋅Kim, R-S⋅R-S, Kim⋅Zhang, H.⋅Lee, S-J⋅S-J, Lee⋅Sheng, H.⋅Loehrer, Pj⋅Gardner, Thomas A⋅Jeng, M-H⋅M-H, Jeng and Kao, Chinghai
British Journal of Cancer, vol. 92, (no. 12), pp. 2233-2239, 2005. | Journal Article
 
Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha -lactalbumin promoter
Li, Xiong⋅Zhang, Jie⋅Gao, Huanling⋅Vieth, Edyta⋅Bae, Kyung-Hee⋅Zhang, Yan-Ping⋅Lee, Sang-Jin⋅Raikwar, Sudhanshu⋅Gardner, Thomas A⋅Hutchins, Gary D⋅VanderPutten, Dale⋅Kao, Chinghai and Jeng, Meei Huey
Molecular Cancer Therapeutics, vol. 4, (no. 12), pp. 1850-1859, 2005. | Journal Article
2004
Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
Hong, Heng⋅Hong, Heng⋅Kao, Chinghai⋅Kao, Chinghai⋅Jeng, Meei Huey⋅Jeng, Meei‐Huey⋅Eble, John N⋅Eble, John N⋅Koch, Michael O⋅Koch, Michael O⋅Gardner, Thomas A⋅Gardner, Thomas A⋅Zhang, Shaobo⋅Zhang, Shaobo⋅Li, Lang⋅Li, Lang⋅Pan, Chong‐Xian⋅Pan, Chong Xian⋅Hu, Zhiqiang⋅Hu, Zhiqiang⋅MacLennan, Gregory T⋅Mac Lennan, Gregory⋅Cheng, Liang and Cheng, Liang
Cancer, vol. 101, (no. 1), pp. 83-9, 2004/Jul/1. | Journal Article
 
Allelic loss of the active X chromosome during bladder carcinogenesis.
Cheng, Liang⋅Mac Lennan, Gregory⋅Pan, Chong Xian⋅Jones, Timothy D⋅Moore, Curtiss R⋅Zhang, Shaobo⋅Gu, Jian⋅Patel, Namrata B⋅Kao, Chinghai and Gardner, Thomas A
Archives of pathology & laboratory medicine. , vol. 128, (no. 2), pp. 187-90, 2004/Feb. | Journal Article
 
Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
Cheng, Liang⋅Zhang, Shaobo⋅Sweeney, Christopher J⋅Kao, Chinghai⋅Gardner, Thomas A and Eble, John N
Anticancer research. , vol. 24, (no. 4), pp. 2135-40, 2004 Jul-Aug. | Journal Article
 
Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
Shirakawa, Toshiro⋅Gotoh, Akinobu⋅Zhang, Zhujun⋅Kao, Chinghai⋅Chung, Leland and Gardner, Thomas A
Urology, vol. 63, (no. 3), pp. 613-8, 2004/Mar. | Journal Article
 
Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus
Lim, Ho Y⋅Ahn, Miwon⋅Chung, Hyun C⋅Gardner, Thomas A⋅Kao, Chinghai⋅Lee, Sang-Jin and Kim, Se J
Cancer Gene Therapy, vol. 11, (no. 8), pp. 532-538, Aug 2004. | Journal Article
2003
High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.
Zeng, Guangyuan⋅Zeng, Guangyuan⋅Hu, Zhiqiang⋅Hu, Zhiqiang⋅Kinch, Michael S.⋅Kinch, Michael S⋅Pan, Chong-Xian⋅Pan, Chong Xian⋅Flockhart, David A.⋅Flockhart, David A⋅Kao, Chinghai⋅Kao, Chinghai⋅Gardner, Thomas A⋅Gardner, Thomas A.⋅Zhang, Shaobo⋅Zhang, Shaobo⋅Li, Lang⋅Li, Lang⋅Baldridge, Lee Ann⋅Baldridge, Lee A⋅Koch, Michael O⋅Koch, Michael O.⋅Ulbright, Thomas M.⋅Ulbright, Thomas M⋅Eble, John N⋅Eble, John N.⋅Cheng, Liang and Cheng, Liang
The American journal of pathology, vol. 163, (no. 6), pp. 2271-6, 2003/Dec. | Journal Article
 
NFATc1 with AP-3 site binding specificity mediates gene expression of prostate-specific-membrane-antigen.
Lee, Sang-Jin⋅Lee, KangRyul⋅Yang, Xiumei⋅Jung, Chaeyong⋅Gardner, Thomas A⋅Kim, Hong-Sup⋅Jeng, Meei Huey and Kao, Chinghai
Journal of molecular biology, vol. 330, (no. 4), pp. 749-60, 2003/Jul/18. | Journal Article
 
Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.
Kubo, Hiroyuki⋅Gardner, Thomas A⋅Wada, Yoshitaka⋅Koeneman, Kenneth S⋅Gotoh, Akinobu⋅Yang, Ling⋅Kao, Chinghai⋅Lim, So D⋅Amin, Mahul B⋅Yang, Hua⋅Black, Margaret E⋅Matsubara, Shigeji⋅Nakagawa, Masayuki⋅Gillenwater, Jay Y⋅Zhau, Haiyen E and Chung, Leland
Human gene therapy, vol. 14, (no. 3), pp. 227-41, 2003/Feb/10. | Journal Article
2002
Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model.
Cheon, Jun⋅Cheon, Jun⋅Moon, Du G⋅Moon, Du Geon⋅Cho, Hyun Yee⋅Cho, Hyun Y⋅Park, Hong S⋅Park, Hong Seok⋅Kim, Je Jong⋅Kim, Je J⋅Gardner, Thomas A⋅Gardner, Thomas A⋅Kao, Chinghai and Kao, Chinghai
International journal of urology : official journal of the Japanese Urological Association, vol. 9, (no. 5), pp. 261-267, May 2002. | Journal Article